Survey Among Healthcare Professionals Treating Patients With Metastatic Breast Cancer in Selected European Countries to Evaluate Their Knowledge on Management of Hyperglycemia When Using Alpelisib

CompletedOBSERVATIONAL
Enrollment

103

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

June 5, 2024

Study Completion Date

June 5, 2024

Conditions
Breast Cancer
Interventions
OTHER

Piqray Prescriber's/HCP guide for hyperglycemia

oncologists/healthcare professionals (HCPs) prescribing Piqray in the EU/EEA were provided with the Piqray Prescriber's/HCP Guide for hyperglycemia (educational material). The educational material aimed to provide oncologists/HCPs prescribing Piqray with additional measures/guidance prior to, and during treatment with Piqray for the identification and management of hyperglycemia.

Trial Locations (1)

Unknown

Novartis Investigative Site, Basel

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY